Back
ESC Professional Premium Access

Intensive reduction of high normal blood pressures: PRINT-TAHA9 randomized clinical trial

Session: Hypertension - Pharmacotherapy
Topic: Pharmacotherapy
Speaker: Associate Professor A. Attar (Shiraz, IR)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Armin Attar

Shiraz University of Medical Sciences, Shiraz (Iran (Islamic Republic of))
0 follower

7 more presentations in this session

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Speaker: Doctor M. Freeman (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Differentiated approach to the treatment of uncomplicated hypertensive crisis

Speaker: Doctor M. Sadulloeva (Tashkent, UZ)

Access
Abstract
Slides
Like
Thumbnail

Blockade of the renin-angiotensin system as a therapeutic target of NAFLD: results of an experimental model of hypercholesterolemia

Speaker: Professor D. Bertolim Precoma (Campina Grande do Sul, BR)

Access
Abstract
Slides
Like
Thumbnail

Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study

Speaker: Doctor F. Goetzinger (Homburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Speaker: Doctor A. Liontos (Ioannina, GR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Hypertension - Pharmacotherapy

Speakers: Associate Professor A. Attar, Doctor M. Freeman, Doctor M. Sadulloeva, Professor D. Bertolim Precoma, Doctor F. Goetzinger...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources